Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy
Condition(s):Bladder CancerLast Updated:March 23, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):Bladder CancerLast Updated:March 23, 2022Unknown status
Condition(s):Prostate Cancer; Prostatic Cancer; Prostate Neoplasms; Prostatic Neoplasms; Cancer of the ProstateLast Updated:July 12, 2019Recruiting
Condition(s):Localized Prostate CancerLast Updated:March 22, 2024Recruiting
Condition(s):Prostate Cancer; Prostatic Cancer; Prostate Neoplasms; Prostatic Neoplasms; Cancer of the ProstateLast Updated:May 9, 2023Completed
Condition(s):Cervical Cancer; Uterine CancerLast Updated:December 26, 2023Recruiting
Condition(s):Localized Prostate CancerLast Updated:March 22, 2024Recruiting
Condition(s):Infiltrating Bladder Urothelial Carcinoma; Recurrent Bladder Carcinoma; Stage I Prostate Cancer; Stage I Renal Cell Cancer; Stage II Bladder Urothelial Carcinoma; Stage II Renal Cell Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage III Renal Cell CancerLast Updated:November 24, 2021Terminated
Condition(s):Prostate CancerLast Updated:April 5, 2019Recruiting
Condition(s):Prostate CancerLast Updated:September 13, 2023Active, not recruiting
Condition(s):Malignant Prostate NeoplasmLast Updated:January 19, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.